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Introduction
Magnetic resonance imaging is the most important imaging method for diagnosis and monitoring of multiple sclerosis. The 2017 revised Mcdonald diagnostic criteria for the diagnosis of multiple sclerosis require the dissemination of lesions in both space and time. Lesion load change is also crucial for the assessment of disease activity, since patients who are assigned with disease modifying therapies and no evidence of disease activity (NEDA) harbor a better prognosis [1, 2, 3, 4] . Radiological progression can be separated into new or enlarged lesions in T2 weighted imaging, and new enhancing lesions on T1 weighted imaging with Gadolinium-based contrast agents (GBCA). While standard imaging protocols for multiple sclerosis have included GBCA, there is increasing evidence that high resolution 3D unenhanced MRI is sufficient to detect the presence of new or enlarged lesions [5] .
Detection of new and enlarged lesions in multiple sclerosis imaging by human raters is time-consuming and limited by inter-and intra-rater variability [6] . As a consequence, manual lesion volumetry and lesion counting has limited sensitivity for new lesion detection. Delineation of new and enlarged lesions can be improved by working on subtraction MRI, but this still requires substantial human user interaction and judgement, as well as manual intensity normalization. A recent study showed that FLAIR subtraction MRI had a sensitivity of 80% for detecting new or enlarged lesions. [7] . Registration errors, flow artifacts and lesion signal intensity differences can result in the detection of false-positive lesions on subtraction images [8] .
Several groups have proposed automated methods for multiple sclerosis lesion segmentation, mostly validated in a cross-sectional fashion. [9, 10, 11, 12] Even where longitudinal data was used to assess the performance of classifiers, consistency of segmentations over time, or the ability to detect new lesions were not investigated [13] . Since MR contrast will differ between time-points, even on the same scanner, and since the borders of MS lesions are often not well defined, automated methods will typically show small differences in the boundaries of lesions at different time-points, even if no lesion growth has taken place. Since even the best automated methods also make false positive and false negative lesion identifications, lesion counts may also not be reliable in a longitudinal setting. Several researchers have proposed methods to harmonize segmentations across two or more time-points. Jain et al propose a joint expectationmaximization (EM) framework for two time-point white matter (WM) lesion segmentation, and the Lesion Segmentation Toolkit, a tool integrated in SPM, has a longitudinal pipeline which adapts existing segmentations across multiple time-points [14, 15] . Meanwhile, Salem et al proposed a logistic regression classifier for detected new and enlarged lesions showing "considerable growth" using features derived from subtraction imaging and deformation fields derived from registration of two time-points. [16] In a companion paper, we have introduced a novel method (DeepSCAN MS) based on convolutional neural networks (CNNs), for multiple sclerosis lesion segmentation, which we demonstrated to outperform previous methods. [17] In this paper, we demonstrate that changes in lesion count and volume change, estimated using our method, do not perform well as a method for separating stable and progressive MS cases. Simultaneous lesion growth and lesion resolution may occur at a single time-point, which will not be apparent from simply observing and those with genuinely new or enlarged lesions. We identify as new lesion tissue only those voxels that were confidently not present at time-point t=0 but that are confidently lesion tissue at time-point t=1. The method requires T1, FLAIR and T2 imaging adhering to modern best-practice imaging standards in MS (specifically, a 3D FLAIR and 3D T1 acquisition), such as those specified in the OFSEP minimal MRI protocol. [19] .
Methods
In this paper, we study the ability of a previously trained deep learning classifier to detect longitudinal changes in T2 lesion load, by several means: lesion counting, overall lesion volume, detecting voxel-by-voxel change using coregistration, detecting voxel-by-voxel confident change using a method which incorporates classifier confidence. We describe the patient cohorts, the deep learning method, and the methods for detecting lesion growth. We utilise data from three sources. The first are MRI datasets of patients with remittingrelapsing multiple sclerosis that were identified from the MS cohort databank of the University of Bern. Use of data for this study was approved by the local ethics committee (Cantonal Ethics Commission Bern, Switzerland 'MS segmentation disease monitoring', approval number 2016-02035) and all patients gave general consent for data storage and analysis of their MRI datasets. This data was from the same centre and scanner as that used for the training of our fully convolutional deep learning classifier (DeepSCAN).
Additional anonymized datasets were provided by Radiology Center Bethanien, (which we subsequently refer to as the Zurich dataset), and from the Klinikum Rechts der Isar, Munich, Germany (which we subsequently refer to as the Munich dataset).
Patient cohorts and MR imaging
Patients from the Bernese MS cohort were included in the Bern dataset if they had at least three consecutive MRI datasets, and were not among the 50 casesused in training of the DeepSCAN classifier. [17] All patients fulfilled the A total of 176 parallel images were acquired with a slice thickness of 1.0 mm).
All patients received Gadobutrol (Gadovist) 0.1 ml/kg bodyweight immediately 6 after the acquisition of the unenhanced T1w sequence.
MR images from the Zurich dataset were acquired using a standardized acquisition protocol on a 3T MRI (Siemens Skyra, Siemens, Erlangen, Germany), 
The DeepSCAN MS lesion classifier
In a previous paper on brain tumor segmentation [21] , we proposed a hybrid of U-net [22] and Densenet [23] , in which the bottleneck layer of the Unet is a single dense block, and in which some of the pooling and upscaling is replaced by dilated convolutions. In a subsequent paper, we introduced a new loss function (label-flip loss), in which the probability that classification output differs from the ground truth used for supervision is used to anneal gradients coming uncertain datapoints, and demonstrated that this loss function leads to improved results in brain segmentation. [24] . In a companion paper to this paper, we trained a classifier, which we call DeepSCAN MS, on fifty cases from the Bernese MS cohort databank [17] . In this section, we first summarize the proce-dure for training the DeepSCAN MS classifier, and then describe its application in detecting longitudinal changes in MS. The DeepSCAN MS classifier is shown in Figure 1 : it is a fully-convolutional neural network trained on fifty cases from the Bernese MS cohort databank, which provides segmentations of white-matter lesions, together with segmentations of the cerebellum, subcortical grey matter structures, and cortical grey and white matter, in MS patients. (In this study we only use the lesion segmentations produced by the classifier.) The network was trained using a combination of focal loss and our previously defined label-flip loss, on lesion labels provided by manual raters, and brain anatomy labels provided by Freesurfer. In label flip loss, for each voxel, and tissue class, the network outputs two probabilities: the probability p that voxel contains the tissue class, and the probability q that the label predicted does not correspond to the label in the ground-truth annotation (i.e., the probability of a 'label flip'). IF BCE stands for the standard binary cross-entropy loss, and y is the target label, then the label-uncertainty loss is:
where
If q is close to zero, and the label is correct, the first term is approximately 8 the ordinary BCE loss: if q is close to 0.5 (representing total uncertainty as to the correct label) the first term tends to zero. This loss therefore attenuates loss in areas of high uncertainty (i.e., where the network is likely to disagree with the ground truth) during training, and indicates areas where segmentation reliability may be poor when applied to new data.
On an internal dataset of 32 patients, the DeepSCAN classifier achieved a mean Dice coefficient of 0.60 versus a manual consensus ground truth for the task of segmenting MS lesions, compared to a mean Dice coefficient of 0.58 between two independent manual raters. This result was sustained when we examined external data from the MSSEG challenge [25] . This dataset consists of fifteen cases, from two centres and three scanners, each rated by seven independent manual raters. Imaging quality is of a similar standard to that used in the Bernese MS cohort. [19] . Versus the independent raters, mean Dice coefficient with the output of DeepSCAN (without retraining on the external data) ranged between 0.56 and 0.61. For comparison, the mean Dice coefficient between the MSSEG raters on the training data ranged between 0.54 and 0.75.
As we have already discussed, manual segmentations of MS lesions have large inter-and intra-rater variability, and so we must accept that this 'ground- Inversion Recovery for Munich) was included in the analysis.
Automated Segmentation by DeepSCAN convolutional neural network
For each patient and time-point we used the DeepSCAN classifier to generate lesion masks and label-flip maps for MS lesions lesions, using the T1-weighted, T2-weighted, and T2 FLAIR imaging as input. To aid in comparison between time-points, these maps were resampled to 1mm 3 isotropic resolution. The classifier also returns a 1mm 3 isotropic skull-stripped FLAIR image in the same space as the lesion and label-flip maps.
Coregistration
In order to compare cases across time-points, it was necessary to register all imaging for each patient to a common space. To avoid biases inherent in registering to a particular time-point, we applied a robust registration technique (the Robust Template method from Freesurfer) to the skull-stripped FLAIR images produced by our CNN tool, in which all time-points are registered to a common patient-specific template . [26] After construction of the template, lesion masks and lesion confidence maps were rigidly registered to the template space using the transforms output by the robust template method.
Lesion change detection by classification uncertainty
We describe here the decision procedure for labelling a voxel as 'new lesion', given lesion mask and label-flip maps at time-points A and B in a common, coregistered space, and a threshold q determining acceptable confidence. We subsequently identified all connected components of "new lesion" tissue.
To improve robustness to coregistration artifacts, all connected components of the new lesion map containing fewer than 12 voxels were deleted.
For the purposes of our initial investigation, we set the value of q to be 0.05:
i.e., we determine a voxel to be classified with confidence if the model predicts a 5% or lower chance of the predicted label disagreeing with the manual rater.
Lesion change detection by threshold margin
A more simplistic methodology for labelling lesions as confidently or uncertainly classified is to set a margin around the ordinary decision threshold, 0.5, and to label all voxels outside of this margin as 'confident'. This method has the advantage that it may be applied to classifiers which do not output a labelflip probability: however, in general the output of modern neural networks is not well calibrated: the scores output by deep networks do not correspond to observed probabilities and are typically overconfident [27] .
Concretely, we set a margin 0 < m < 0. For the purposes of our initial investigation, we set the value of m to be 0.45: i.e., we determine a voxel to be classified as confident lesion if the model predicts a score of .95 or greater and to be classified as confident non-lesion if the model predicts a score of 0.05 or less.
Evaluation
We compared our proposed methods to four other methods on our internal (Bernese) test set: absolute change in lesion volume, relative change in lesion volume, change in lesion count, and total new lesion volume (equivalent to our method with q = 0.5). To test the power of these measures to separate progressive and stable time-points, we plotted the receiver-operating characteristic (ROC) curves for each of the above methods. While ROC-AUC analysis gauges the ability of a metric to separate positive and negative examples across all operating thresholds, clinical applicability required that a particular threshold is chosen. .We therefore tested the performance of our metrics at an operating threshold corresponding to 'no lesion change' (i.e. lesion count > 0, lesion volume change > 0, and new lesion volume > 0).
We assessed the sensitivity of our method to its parameters, by comparing the ROC curves of the method at different values of uncertainty threshold q, margin m, and small-growth threshold.
Results
Twenty-six patients from the Bernese MS databank satisfied the inclusion criteria, of which 16 were judged from radiological reports to have no lesion changes in any of the time-points, and so were labelled as having stable disease (SD). The remaining 10 cases were judged to have progressive disease (PD).
The mean number of time-points per patient was 4.4 for the progressive patients, and 4.9 for the stable patients. Among the ten progressive patients, there were a total of 13 time-points where the radiological reports indicated progression, meaning that approximately 30% of the time-points in those patients showed lesion progression. Mean time between examinations for 223 days, with a standard deviation of 98 days.
ROC-AUC analysis
For each proposed method, we computed the area under the receiver-operating characteristic for the bernese dataset: see Figure 2 . Lesion counting performed proposed method using network-derived uncertainty had a ROC-AUC of 0.999.
Performance at meaningful thresholds
Results of this analysis are shown in Table 1 .
For lesion counting, this metric leads to a total of 33 time-points being identified as progressive, when in fact they were stable according to radiological The best-performing method according to area under the ROC curve, according to our initial analysis, was achieved using our uncertainty-based method with an uncertainty threshold of 0.05: i.e. voxels which had a flip-probability greater than 0.05 at either time-point are not used to calculate lesion change. At a fixed operating threshold, meanwhile, our two proposed methods performed similarly in terms of accuracy, but the method derived from label-flip confidence had perfect sensitivity and lower PPV, while the method derived from a margin around the threshold had perfect PPV and lower sensitivity.
Both of these methods rely on a parameter which can be varied, with an effect on the performance. In this section we investigate the effect of changing those parameters.
Effect of changing uncertainty threshold
For uncertainty threshold values lower than the one we initially selected (0.0005, 0.001 and 0.01), the AUC was slightly reduced, at 0.92. At larger uncertainty thresholds than initially selected, the AUC was also slightly lower:
a threshold of 0.1 gave an AUC of 0.99, and a threshold of 0.2 gave an AUC of 0.96.
Effect of changing classification margin
The effect of changing the classification margin was much more drastic. By setting a narrower classification margin (0.15), we were able to achieve an AUC close to the performance of the uncertainty-based method (AUC = 0.998). A slightly larger margin of 0.2 gave worse performance (AUC = 0.96), while a slightly narrower margin of 0.1 led to a smaller decrease in performance (AUC = 0.996).
Effect of changing threshold for growth
In the method as described, areas of growth below 12 voxels do not count towards lesion growth. The method is reasonably robust to changes in this lesion-growth threshold. A larger threshold of 24 voxels led to an AUC of 0.96, while a smaller threshold of 6 voxels led to an AUC of 0.997. Not applying a threshold yielded an AUC of 0.98.
Performance on external data
Several authors have reported difficulties of automated methods for MS lesion segmentation to perform on out-of-sample data. [25, 11] In our previous paper, we already validated that performance of the DeepSCAN MS classifier is not substantially degraded when applied to data adhering to similar protocol standards from different centres [17] . In this section, we report the ability of the uncertainty-based method, as described above to identify progressive timepoints in external data. The method was applied to data from eight patients, each having four consecutive time-points (thirty-two datsets, twenty-four after baseline) from the Zurich dataset. This data was supplied full anonymized.
In a second test of generalization, the full lesion segmentation algorithm and uncertainty-based method was containerized using Docker, and provided to the imaging at 3T can reduce or eliminate the need for contrast-enhanced sequences. [5, 7] The method in this paper proposes to track changes in lesion load by lever- found. We therefore tend to prefer the uncertainty-based method.
Furthermore, our method (trained on fifty cases from a single institution) also performs well when applied to two datasets from external centres. While detection of progression was perfect on the internal validation set, the method failed to identify progression at two time-points in the Zurich dataset and eight time-points from the Munich data set. This was caused by small new lesions which were correctly identified, but too small to be identified confidently. For example, the two cases mislabelled as stable in the Zurich dataset each had a single, small new lesion. In the first case this was a small faint lesion in deep white matter, and in the second it was a small periventricular lesion.
In both cases these lesions were correctly segmented by DeepSCAN, but not at a sufficient level of confidence to deem them confident new lesion tissue.
Representative slices from these two cases are shown in Figures 3 and 4 Other methods included graph cuts, i.e. graph-based segmentation techniques that employ seed points set by the user and a cost function or active contouring using prior information. These methods still require a degree of human interaction, are time consuming and require an expert-in-the-loop. Currently, 
